14158 Results (Page 29 of 567)
All Market Research Reports
Japan Chronic Inflammatory Demyelinating Polyneuritis Therapeutics Market Analysis
Japan Chronic Inflammatory Demyelinating Polyneuritis Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. A acquired immune-mediated neuropathy that affects peripheral nerves and nerve roots, chronic inflammatory demyelinating polyneuropathy (CIDP; also known as chronic inflammatory demyelinating polyradiculoneuropathy) is characterised by a progressive or relapsing-remitting course of symmetric weakness of the proximal and distal muscles. Growing government spending and disease awareness have been the market's main drivers for Chronic Inflammatory Demyelinating Polyneuritis (CIDP) Therapeutics. Bio products laboratory Ltd., Momenta Pharmaceuticals, Grifols, Baxter, Octapharma, Shire, Kedrion SPA, Misubishi Tanabe Pharma Corporation, CSL Behring, and Teijin Pharma Ltd. are global firms in the Chronic Inflammatory Demyelinating Polyneuritis (CIDP) Therapeutics market.
Japan Charcot-Marie-Tooth Disease (CMT) Therapeutics Market Analysis
Japan Charcot-Marie-Tooth Disease (CMT) Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The majority of hereditary peripheral neuropathies are Charcot-Marie-Tooth (CMT) illness, commonly referred to as hereditary motor and sensory neuropathy (HMSN). Genes that support or generate proteins important in the construction and operation of the myelin sheath or the peripheral nerve axon are mutated, leading to CMT. An increase in genetic illnesses will result in more innovations being made in this area, which will enhance market growth because there are many genes that cause these problems. The above-mentioned forecast period will witness the emergence of the market for Charcot Marie-Tooth disease due to multiple prospects that will be heightened by the rising focus on targeted therapies and the favorable government regulations. Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp., Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc. are some of the major players in the Charcot Marie Tooth Disease Market.
Japan Batten's Disease (CLN-2) Therapeutics Market Analysis
Japan Batten?s Disease (CLN-2) Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. Neuronal Ceroid Lipofuscinosis (NCL), often known as Batten disease, is a rare and severe autosomal recessive neurodegenerative lysosomal storage condition brought on by cellular buildup of aberrant auto-fluorescent lipoproteins (lipofuscin). Seizures and a progressive loss of movement, verbal, visual, and cognitive abilities are features of this neurodegenerative condition that primarily affects the nerve system. Research advancements in nanotechnology could result in the creation of fresh therapies that would benefit persons who suffer from this ailment. Additionally, it is a paediatric brain condition that is extremely rare yet progresses quickly. As a result, Batten's Disease may be exacerbated by the predicted rising prevalence of disease. Therapeutics market (CLN-2). The market for Batten's Disease (CLN-2) Therapeutics is constrained by a lack of treatment and symptoms that are challenging to identify. Regenxbio, Polaryx Therapeutics and Abeona Therapeutics are some of the key players in the market.
Vietnam Genomics Market Analysis
The Vietnam Genomics market was valued at $163.2 Mn in 2023 and is predicted to grow at a CAGR of 16.73% from 2023 to 2030, to $482.1 Mn by 2030. The key drivers of the market include increasing public awareness, the need for advancements in cancer treatments, and increasing trend of personalized medicines. The prominent players of the Vietnam genomics market are Gene Solutions, Medics Genetics, Vinmec Research Institute of Stem Cell and Gene Technology (VRISG), and Medical Genetics Institute (MGI), among others.
Saudi Arabia Genomics Market Analysis
The Saudi Arabia Genomics market was valued at $555.1 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $1,768.1 Mn by 2030. The key drivers of the market include rising prevalence of diseases, increasing applications of genomics, the need for advancements in cancer treatments, and the rising demand for personalized medicines. The prominent players of the Saudi Arabia Genomics Market are NoorDx, Al Farabi Labs, Novo Genomics, Anwa Labs, Saudi Advanced Medical Lab (SAML), Saudi-German Genomic Centre, among others.
Mexico Genomics Market Analysis
The Mexico Genomics market was valued at $489.8 Mn in 2023 and is predicted to grow at a CAGR of 16.75% from 2023 to 2030, to $1,448 Mn by 2030. The key drivers of the market include the need for advancements in cancer treatments, increasing trend of personalized medicines, and increasing genomics projects. The prominent players of the Mexico genomics market are National Institute of Genomic Medicine (INMEGEN), the National Laboratory of Genomics for Biodiversity of Mexico (LANGEBIO), Genomica Medica, BGI Mexico, and National Autonomous University of Mexico (UNAM), among others.
Kenya Genomics Market Analysis
The Kenya Genomics market was valued at $22.9 Mn in 2023 and is predicted to grow at a CAGR of 17.6% from 2023 to 2030, to $71.1 Mn by 2030. The key drivers of the market include the growing infectious disease burden, the need for advancements in cancer treatments, and the increasing trend of personalized medicines. The prominent players of the Kenya Genomics Market are Kenyatta National Hospital (KNH), Kenya Medical Research Institute (KEMRI), Bioinformatics Institute of Kenya (KIBS), Illumina, Thermo Fisher Scientific, Qiagen, and Agilent, among others.
Egypt Lipid Disorder Therapeutics Market Analysis
The Egypt Lipid Disorder Therapeutics Market was valued at $65.7 Mn in 2023 and is predicted to grow at a CAGR of 13.86% from 2023 to 2030, to $162.9 Mn by 2030. Egypt's Lipid Disorder Therapeutics Market is growing due to the Rising Prevalence of Non-Communicable Diseases, Growing Awareness and Focus on Chronic Disease Management, and Rising Demand for Digitalized Healthcare Services. The industry is primarily dominated by players such as Sanofi, Sun Pharmaceutical Industries Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Takeda Pharmaceutical Company Limited, AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Japan ATTR (Transthyretin Amyloidosis) Therapeutics Market Analysis
Japan ATTR (Transthyretin Amyloidosis) Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. An rare and progressive condition known as ATTR (Transthyretin Amyloidosis) is characterised by the buildup of aberrant proteins in the body, including misTTR. The market for treatments for transthyretin amyloidosis is primarily driven by the expansion of the population and the availability of favourable reimbursement programmes. The market is predicted to increase as a result of strategic actions done by major players such raising knowledge of the target conditions like ATTR and the long-term advantages of treatments that are currently accessible. The market for treating transthyretin amyloidosis is currently constrained by a number of factors, including low awareness of the condition in developing nations, misdiagnosis of the condition, high costs of disease diagnosis and treatment, the lack of adequate clinical trials, and the absence of effective medications. Pfizer Inc., Johnson & Johnson Services, Inc., Ionis Pharmaceuticals, Alnylam Pharmaceuticals, BridgeBio Pharma, Bristol-Myers Squibb Company, Acrotech Biopharma, AstraZeneca, Astellas Pharma, Inc., Prothena, SOM Biotech, and numerous others are global competitors in the ATTR (Transthyretin Amyloidosis) market.
Japan Ankylosing Spondylitis Therapeutics Market Analysis
Japan Ankylosing Spondylitis Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Ankylosing spondylitis is a kind of arthritis that affects connective tissues. The sacroiliac joints, which connect the spine to the pelvis, become inflamed, but in extreme situations, the spine's bones might fuse together and become very inflexible. A rough estimate of 1.1 Mn Americans, or one out of every 200 adults, are impacted. Abbvie, Amgen, Eli Lilly, Janssen, Merck, Pfizer, Novartis, UCB, and many other leading companies are active in the ankylosing spondylitis global market. To increase their market share, these businesses engage in strategic alliances and acquisitions in addition to concentrating on research and development to bring novel therapies to market.
Japan Adrenoleukodystrophy (ALD) Therapeutics Market Analysis
Japan Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Japan Adrenoleukodystrophy (ALD) drugs market.
Venezuela Bioinformatics Market Analysis
The Venezuela bioinformatics market is projected to grow from $xx Mn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The main factor driving the growth would be increased government focus on improving healthcare. The market is segmented by technology and by application. Some of the major players include Partek, Bruker Corporation, NEC, Genedata, and Thermo Fisher Scientific.
Argentina Acne Drugs Market Analysis
This report presents a strategic analysis of the Argentina Acne Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Acne Drugs Market, offering unmatched value, accuracy and expert insights.
Denmark Oncology Clinical Trials Market Analysis
This report presents a strategic analysis of the Denmark Oncology Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Denmark Oncology Clinical Trials Market, offering unmatched value, accuracy and expert insights.
China Virtual Clinical Trials Market Analysis
This report presents a strategic analysis of the China Virtual Clinical Trials Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the China Virtual Clinical Trials Market, offering unmatched value, accuracy and expert insights.
Argentina Dermatology Drugs Market Analysis
This report presents a strategic analysis of the Argentina Dermatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Dermatology Drugs Market, offering unmatched value, accuracy and expert insights.
Argentina Cardiovascular Diseases Therapeutics Market Analysis
This report presents a strategic analysis of the Argentina Cardiovascular Diseases Therapeutics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Argentina Cardiovascular Diseases Therapeutics Market, offering unmatched value, accuracy and expert insights.
Libya Infectious Disease Drugs Market Analysis
This report presents a strategic analysis of the Libya Infectious Disease Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Libya Infectious Disease Drugs Market, offering unmatched value, accuracy and expert insights.
Finland Breast Cancer Therapeutics Market Analysis
The Finland breast cancer therapeutics market is expected to witness significant growth from $38 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the year 2022-2030. The introduction of new targeted therapies in Finland is one of the main market drivers of Finland's breast cancer therapeutics market. The market is segmented by therapy, by cancer type, and by distribution channel. Some of the major companies in Finland's breast cancer therapeutics market are Montinutra, Amgen, and AstraZeneca.
Indonesia Rheumatology Drugs Market Analysis
This report presents a strategic analysis of the Indonesia Rheumatology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Indonesia Rheumatology Drugs Market, offering unmatched value, accuracy and expert insights.
Indonesia Medical and Diagnostic Laboratory Service Market Analysis
This report presents a strategic analysis of the Indonesia Medical and Diagnostic Laboratory Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Indonesia Medical and Diagnostic Laboratory Service Market, offering unmatched value, accuracy, and expert insights.
Indonesia Cardiovascular Diseases Therapeutics Market Analysis
The Indonesia cardiovascular disease therapeutics is projected to grow from $976 Mn in 2022 to $1,706 Mn in 2030 with a CAGR of 7.22% for the year 2022-2030. Rapid urbanization leading to shifting lifestyle behaviours in the population of Indonesia resulting in the increased incidence of cardiovascular diseases is responsible for the growth of the market. The Indonesia cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Combiphar, Ivosights, and Bayer are the major players in the Indonesia cardiovascular disease therapeutics market.
Brazil Vitamin and Minerals Market Analysis
This report presents a strategic analysis of the Brazil Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Vitamin and Minerals Market, offering unmatched value, accuracy and expert insights.
Italy Interstitial Cystitis Therapeutics Market Analysis
Italy Interstitial Cystitis Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 30. The global market is expanding as a result of a rise in the frequency of interstitial cystitis and support for research. Major global players in this market are Amneal Pharmaceuticals Inc, Astellas Pharma Inc, Aurobindo Pharma Ltd, Bayer AG, Cadila Healthcare Ltd, Eli Lilly and Co, Hikma Pharmaceuticals Plc, Intas Pharmaceuticals Ltd, Johnson and Johnson, Kyorin Pharmaceutical Co. Ltd, Mission Pharmacal Co, Perrigo Co. Plc, Pfizer Inc, Purdue Pharma LP, Seikagaku Corp, Sun Pharmaceutical Industries Ltd, Taro Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Viatris Inc.
Italy Digital Health Market Analysis
The Italy Digital Health market is projected to grow from $5.06 Bn in 2022 to $19.16 Bn by 2030, registering a CAGR of 18.1% during the forecast period of 2022 - 2030. Driven by factors such as government policies, high penetration of smartphones, and technological developments, the market is segmented by solution, deployment, and by end-use. Some of the major players include Noon Care, Ultraspecialisti & HelParkinson.
